Biontech to hold press conference to provide an update on covid-19 vaccine development program

Mainz, germany, december 02, 2020 (globe newswire) – biontech se (nasdaq: bntx, “biontech” or “the company”) will hold a press conference including a video webcast on wednesday, december 2, 2020, to provide an update on the status of the covid-19 vaccine development program of its lead vaccine candidate bnt162b2. the event will be held in english:

BNTX Ratings Summary

BNTX Quant Ranking